Improving Combined Buprenorphine-Behavioral Treatment
改善丁丙诺啡联合行为治疗
基本信息
- 批准号:7185762
- 负责人:
- 金额:$ 87.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-10 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcquired Immunodeficiency SyndromeAddressAdoptedAdoptionAmbulatory Care FacilitiesBehavior TherapyBuprenorphineClinicClinical TrialsClinical Trials Cooperative GroupCocaineCommunitiesComputersCounselingCriminal JusticeDrug abuseFutureGoalsGrantHealth Care CostsIncentivesKnowledgeLeftMaintenanceManualsMeasuresModificationOpiate AddictionOpioidOutcomeOutcome MeasureOutpatientsPatientsPharmacotherapyProceduresProcessPsychological reinforcementPublic HealthRandomizedRelative (related person)ResearchResearch DesignResearch PersonnelResourcesRisk BehaviorsRuralServicesSocietiesStandards of Weights and MeasuresSubstance abuse problemTechnologyTherapeuticTimeTrainingTreatment CostVermontbasecomputerizedcontingency managementcostcost effectivecost effectivenesshigh risk behaviorimprovednovel strategiesoutreachprogramsrural areasubstance abusertreatment programurban areavoucher
项目摘要
DESCRIPTION (provided by applicant):
In this competing continuation we propose to continue and expand our prior aims. First, we will continue our study of computerized treatment. In a prior trial, computer-delivered Community Reinforcement Approach (CRA) with contingency management (CM) was as effective as therapist-delivered CRA with CM. The design of that study, however, did not indicate whether the computer-delivered CRA produced increases in therapeutic outcomes over that produced by the CM procedures alone. Thus, we propose to isolate the contribution of the computerized treatment to therapeutic outcomes. Second, we will examine the efficacy of a component of CRA, therapist-delivered facilitation of treatment goals and outreach services (FOS) that cannot be computerized. The efficacy of FOS has not been previously examined.
In the process, we will address the infrequently acknowledged problem of rural opioid dependence. The aim of this project is to address this serious public health concern by continuing the first and one of only two outpatient clinics providing pharmacotherapies for opioid dependence in the State of Vermont.
Opioid-dependent outpatients will receive buprenorphine maintenance across two clinical trials. In the first, patients will be randomized to one of two treatments: (1) computer-delivered CRA along with CM; or (2) CM alone. In the second, patients will be randomized to one of two treatments: (1) therapist-delivered FOS with computer-delivered CRA and CM; or (2) computer-delivered CRA and CM. CM procedures will target both opioid and cocaine abstinence in both trials. Primary outcome measures will include abstinence, HIV-risk behavior, retention and cost-effectiveness.
Overall, this research will contribute new empirical information about the efficacy of two approaches of providing CRA with CM. Such information may result in more cost-effective treatment and facilitate dissemination. Moreover, the computerization of substance-abuse treatment may positively impact the treatment field. Finally, this project will contribute positively to this region's public health by providing a substantial portion of all outpatient pharmacotherapy services for opioid dependence in the State of Vermont.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Warren K Bickel其他文献
Warren K Bickel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Warren K Bickel', 18)}}的其他基金
Longitudinal Study of Recovery: Psychosocial Functioning, Relapse, and Neuro-Behavioral Markers
康复的纵向研究:心理社会功能、复发和神经行为标志物
- 批准号:
10577761 - 财政年份:2022
- 资助金额:
$ 87.06万 - 项目类别:
An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology
用于理解可卡因使用障碍机制的实验医学方法:强化病理学
- 批准号:
10454007 - 财政年份:2022
- 资助金额:
$ 87.06万 - 项目类别:
Longitudinal Study of Recovery: Psychosocial Functioning, Relapse, and Neuro-Behavioral Markers
康复的纵向研究:心理社会功能、复发和神经行为标志物
- 批准号:
10367669 - 财政年份:2022
- 资助金额:
$ 87.06万 - 项目类别:
Experimental Tobacco Marketplace: Forecasting the Health Equity of Novel Tax Proposals
实验性烟草市场:预测新税收提案的健康公平性
- 批准号:
10522270 - 财政年份:2022
- 资助金额:
$ 87.06万 - 项目类别:
Experimental Tobacco Marketplace: Forecasting the Health Equity of Novel Tax Proposals
实验性烟草市场:预测新税收提案的健康公平性
- 批准号:
10661063 - 财政年份:2022
- 资助金额:
$ 87.06万 - 项目类别:
An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology
用于理解可卡因使用障碍机制的实验医学方法:强化病理学
- 批准号:
10661032 - 财政年份:2022
- 资助金额:
$ 87.06万 - 项目类别:
Testing Reinforcer Pathology: Mechanisms and Interventions to Change Alcohol Valuation
测试强化物病理学:改变酒精估值的机制和干预措施
- 批准号:
10001412 - 财政年份:2019
- 资助金额:
$ 87.06万 - 项目类别:
Testing Reinforcer Pathology: Mechanisms and Interventions to Change Alcohol Valuation
测试强化物病理学:改变酒精估值的机制和干预措施
- 批准号:
10679071 - 财政年份:2019
- 资助金额:
$ 87.06万 - 项目类别:
Translational approaches to TMS treatment development for smoking
吸烟 TMS 治疗开发的转化方法
- 批准号:
10053029 - 财政年份:2019
- 资助金额:
$ 87.06万 - 项目类别:
Testing Reinforcer Pathology: Mechanisms and Interventions to Change Alcohol Valuation
测试强化物病理学:改变酒精估值的机制和干预措施
- 批准号:
10259857 - 财政年份:2019
- 资助金额:
$ 87.06万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 87.06万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 87.06万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 87.06万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 87.06万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 87.06万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 87.06万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 87.06万 - 项目类别: